![](/images/general/no_picture/200_user.png)
Long D Pham
Examiner (ID: 4097, Phone: (571)270-5573 , Office: P/2691 )
Most Active Art Unit | 2691 |
Art Unit(s) | 2691, 2618, 2629 |
Total Applications | 886 |
Issued Applications | 640 |
Pending Applications | 43 |
Abandoned Applications | 203 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 17472525
[patent_doc_number] => 20220080029
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => COMPOSITION COMPRISING SERICIN FOR TREATING, PREVENTING, OR ALLEVIATING FATTY LIVER, AND METHOD OF PREPARING SAME
[patent_app_type] => utility
[patent_app_number] => 17/420130
[patent_app_country] => US
[patent_app_date] => 2019-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3210
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17420130
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/420130 | COMPOSITION COMPRISING SERICIN FOR TREATING, PREVENTING, OR ALLEVIATING FATTY LIVER, AND METHOD OF PREPARING SAME | Dec 22, 2019 | Abandoned |
Array
(
[id] => 16749923
[patent_doc_number] => 20210101932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR PD-L1
[patent_app_type] => utility
[patent_app_number] => 17/044868
[patent_app_country] => US
[patent_app_date] => 2019-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13303
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17044868
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/044868 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR PD-L1 | Dec 22, 2019 | Pending |
Array
(
[id] => 15895339
[patent_doc_number] => 20200147188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => THERAPEUTIC COMPOSITION CONTAINING ANTITHROMBIN GAMMA
[patent_app_type] => utility
[patent_app_number] => 16/709499
[patent_app_country] => US
[patent_app_date] => 2019-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7897
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16709499
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/709499 | THERAPEUTIC COMPOSITION CONTAINING ANTITHROMBIN GAMMA | Dec 9, 2019 | Abandoned |
Array
(
[id] => 17383946
[patent_doc_number] => 20220031798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => METHODS AND COMPOSITIONS FOR THE TREATMENT OF OPIOID DEPENDENCE AND FOR THE TREATMENT OF PAIN
[patent_app_type] => utility
[patent_app_number] => 17/298664
[patent_app_country] => US
[patent_app_date] => 2019-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5912
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17298664
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/298664 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF OPIOID DEPENDENCE AND FOR THE TREATMENT OF PAIN | Dec 3, 2019 | Pending |
Array
(
[id] => 15934207
[patent_doc_number] => 20200158737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => METHODS OF MEASURING UBIQUITIN-LIKE MODIFICATIONS
[patent_app_type] => utility
[patent_app_number] => 16/688235
[patent_app_country] => US
[patent_app_date] => 2019-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14612
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16688235
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/688235 | METHODS OF MEASURING UBIQUITIN-LIKE MODIFICATIONS | Nov 18, 2019 | Pending |
Array
(
[id] => 15556793
[patent_doc_number] => 20200062808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => PEPTIDES AND COMPOSITIONS FOR PREVENTION OF CELL ADHESION AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/680366
[patent_app_country] => US
[patent_app_date] => 2019-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7100
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16680366
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/680366 | Peptides and compositions for prevention of cell adhesion and methods of using same | Nov 10, 2019 | Issued |
Array
(
[id] => 17602902
[patent_doc_number] => 11331371
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-17
[patent_title] => Labyrinthopeptins as anti-viral agents
[patent_app_type] => utility
[patent_app_number] => 16/665956
[patent_app_country] => US
[patent_app_date] => 2019-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 21
[patent_no_of_words] => 21053
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16665956
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/665956 | Labyrinthopeptins as anti-viral agents | Oct 27, 2019 | Issued |
Array
(
[id] => 17343965
[patent_doc_number] => 20220010296
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => METHODS AND COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/288798
[patent_app_country] => US
[patent_app_date] => 2019-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33805
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17288798
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/288798 | METHODS AND COMPOSITIONS | Oct 23, 2019 | Pending |
Array
(
[id] => 16421908
[patent_doc_number] => 20200347106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => COMPOSITIONS AND METHODS OF USING ISLET NEOGENESIS PEPTIDES AND ANALOGS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/658218
[patent_app_country] => US
[patent_app_date] => 2019-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22890
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16658218
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/658218 | COMPOSITIONS AND METHODS OF USING ISLET NEOGENESIS PEPTIDES AND ANALOGS THEREOF | Oct 20, 2019 | Abandoned |
Array
(
[id] => 15496235
[patent_doc_number] => 20200048306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => PRODRUG OF AN ICE INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 16/657191
[patent_app_country] => US
[patent_app_date] => 2019-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7158
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16657191
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/657191 | PRODRUG OF AN ICE INHIBITOR | Oct 17, 2019 | Abandoned |
Array
(
[id] => 17258476
[patent_doc_number] => 20210371461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => Novel chemiluminescent substrates for Factor Xa
[patent_app_type] => utility
[patent_app_number] => 17/285098
[patent_app_country] => US
[patent_app_date] => 2019-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15086
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17285098
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/285098 | Novel chemiluminescent substrates for Factor Xa | Oct 16, 2019 | Pending |
Array
(
[id] => 16153859
[patent_doc_number] => 20200215162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => Methods for Producing Stable Therapeutic Formulations in Aprotic Polar Solvents
[patent_app_type] => utility
[patent_app_number] => 16/600722
[patent_app_country] => US
[patent_app_date] => 2019-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15389
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16600722
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/600722 | Methods for Producing Stable Therapeutic Formulations in Aprotic Polar Solvents | Oct 13, 2019 | Abandoned |
Array
(
[id] => 18800123
[patent_doc_number] => 11833269
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-05
[patent_title] => Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
[patent_app_type] => utility
[patent_app_number] => 16/595481
[patent_app_country] => US
[patent_app_date] => 2019-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 7953
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16595481
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/595481 | Hyaluronic acid-collagen matrices for dermal filling and volumizing applications | Oct 7, 2019 | Issued |
Array
(
[id] => 17214502
[patent_doc_number] => 20210347839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => Disease Treatment Drug Based on Mesenchymal-Stem-Cell Mobilization
[patent_app_type] => utility
[patent_app_number] => 17/282872
[patent_app_country] => US
[patent_app_date] => 2019-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13378
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17282872
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/282872 | Disease Treatment Drug Based on Mesenchymal-Stem-Cell Mobilization | Oct 3, 2019 | Pending |
Array
(
[id] => 15405431
[patent_doc_number] => 20200023037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-23
[patent_title] => PTD-SMAD7 THERAPEUTICS
[patent_app_type] => utility
[patent_app_number] => 16/584608
[patent_app_country] => US
[patent_app_date] => 2019-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38267
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16584608
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/584608 | PTD-SMAD7 THERAPEUTICS | Sep 25, 2019 | Abandoned |
Array
(
[id] => 17200227
[patent_doc_number] => 20210340322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => AMPHIPHILIC POLY (AMINO ACID), BLOCK COPOLYER USING THE AMPHIPHILIC POLY (AMINO ACID), AND COMPLEX INCLUDING THE AMPHIPHILIC POLY (AMINO ACID) OR THE BLOCK COPOLYMER AND NUCLEIC ACID
[patent_app_type] => utility
[patent_app_number] => 17/280058
[patent_app_country] => US
[patent_app_date] => 2019-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10229
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 243
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17280058
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/280058 | AMPHIPHILIC POLY (AMINO ACID), BLOCK COPOLYER USING THE AMPHIPHILIC POLY (AMINO ACID), AND COMPLEX INCLUDING THE AMPHIPHILIC POLY (AMINO ACID) OR THE BLOCK COPOLYMER AND NUCLEIC ACID | Sep 24, 2019 | Pending |
Array
(
[id] => 17952453
[patent_doc_number] => 11478527
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-25
[patent_title] => FGF receptor ligands for treating diabetes and obesity
[patent_app_type] => utility
[patent_app_number] => 16/574151
[patent_app_country] => US
[patent_app_date] => 2019-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5346
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16574151
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/574151 | FGF receptor ligands for treating diabetes and obesity | Sep 17, 2019 | Issued |
Array
(
[id] => 17052169
[patent_doc_number] => 20210261603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => SITE-SPECIFIC SERINE ADP-RIBOSYLATED PROTEINS AND PEPTIDES AND METHOD FOR PRODUCING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/276772
[patent_app_country] => US
[patent_app_date] => 2019-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15604
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17276772
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/276772 | SITE-SPECIFIC SERINE ADP-RIBOSYLATED PROTEINS AND PEPTIDES AND METHOD FOR PRODUCING THE SAME | Sep 16, 2019 | Pending |
Array
(
[id] => 17420028
[patent_doc_number] => 11253456
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-22
[patent_title] => Anti-inflammatory peptides, and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/569159
[patent_app_country] => US
[patent_app_date] => 2019-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 33
[patent_no_of_words] => 21981
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16569159
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/569159 | Anti-inflammatory peptides, and uses thereof | Sep 11, 2019 | Issued |
Array
(
[id] => 17183851
[patent_doc_number] => 20210330736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => USE OF A PDE11 OR PDE2 INHIBITOR FOR THE TREATMENT OF PARKINSON'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/271978
[patent_app_country] => US
[patent_app_date] => 2019-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14047
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17271978
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/271978 | USE OF A PDE11 OR PDE2 INHIBITOR FOR THE TREATMENT OF PARKINSON'S DISEASE | Sep 4, 2019 | Pending |